Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease.

Covey DP, Dantrassy HM, Yohn SE, Castro A, Conn PJ, Mateo Y, Cheer JF.

Neuropsychopharmacology. 2018 Jun 1. doi: 10.1038/s41386-018-0107-8. [Epub ahead of print]

PMID:
29925886
2.

Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus.

Kolata SM, Nakao K, Jeevakumar V, Farmer-Alroth EL, Fujita Y, Bartley AF, Jiang SZ, Rompala GR, Sorge RE, Jimenez DV, Martinowich K, Mateo Y, Hashimoto K, Dobrunz LE, Nakazawa K.

Neuropsychopharmacology. 2018 May;43(6):1445-1456. doi: 10.1038/npp.2017.296. Epub 2017 Dec 6.

3.

Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens.

Mateo Y, Johnson KA, Covey DP, Atwood BK, Wang HL, Zhang S, Gildish I, Cachope R, Bellocchio L, Guzmán M, Morales M, Cheer JF, Lovinger DM.

Neuron. 2017 Dec 6;96(5):1112-1126.e5. doi: 10.1016/j.neuron.2017.11.012.

PMID:
29216450
4.

Endocannabinoid modulation of dopamine neurotransmission.

Covey DP, Mateo Y, Sulzer D, Cheer JF, Lovinger DM.

Neuropharmacology. 2017 Sep 15;124:52-61. doi: 10.1016/j.neuropharm.2017.04.033. Epub 2017 Apr 25. Review.

PMID:
28450060
5.

Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum.

Johnson KA, Mateo Y, Lovinger DM.

Neuropharmacology. 2017 May 1;117:114-123. doi: 10.1016/j.neuropharm.2017.01.038. Epub 2017 Jan 31.

6.

Dopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum.

Salinas AG, Davis MI, Lovinger DM, Mateo Y.

Neuropharmacology. 2016 Sep;108:275-83. doi: 10.1016/j.neuropharm.2016.03.049. Epub 2016 Mar 30.

7.

Increased presynaptic regulation of dopamine neurotransmission in the nucleus accumbens core following chronic ethanol self-administration in female macaques.

Siciliano CA, Calipari ES, Yorgason JT, Lovinger DM, Mateo Y, Jimenez VA, Helms CM, Grant KA, Jones SR.

Psychopharmacology (Berl). 2016 Apr;233(8):1435-43. doi: 10.1007/s00213-016-4239-4. Epub 2016 Feb 19.

8.

Chronic ethanol self-administration in macaques shifts dopamine feedback inhibition to predominantly D2 receptors in nucleus accumbens core.

Siciliano CA, Calipari ES, Yorgason JT, Mateo Y, Helms CM, Lovinger DM, Grant KA, Jones SR.

Drug Alcohol Depend. 2016 Jan 1;158:159-63. doi: 10.1016/j.drugalcdep.2015.10.031. Epub 2015 Nov 10.

9.

Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.

Liu G, Sgobio C, Gu X, Sun L, Lin X, Yu J, Parisiadou L, Xie C, Sastry N, Ding J, Lohr KM, Miller GW, Mateo Y, Lovinger DM, Cai H.

Hum Mol Genet. 2015 Sep 15;24(18):5299-312. doi: 10.1093/hmg/ddv249. Epub 2015 Jun 29.

10.

Chronic methylphenidate exposure during adolescence reduces striatal synaptic responses to ethanol.

Crowley NA, Cody PA, Davis MI, Lovinger DM, Mateo Y.

Eur J Neurosci. 2014 Feb;39(4):548-56. doi: 10.1111/ejn.12426. Epub 2013 Nov 18.

11.

Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging.

Jaaro-Peled H, Niwa M, Foss CA, Murai R, de Los Reyes S, Kamiya A, Mateo Y, O'Donnell P, Cascella NG, Nabeshima T, Guilarte TR, Pomper MG, Sawa A.

Hum Mol Genet. 2013 Apr 15;22(8):1574-80. doi: 10.1093/hmg/ddt007. Epub 2013 Jan 11.

12.

Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing.

Cachope R, Mateo Y, Mathur BN, Irving J, Wang HL, Morales M, Lovinger DM, Cheer JF.

Cell Rep. 2012 Jul 26;2(1):33-41. doi: 10.1016/j.celrep.2012.05.011. Epub 2012 Jul 11.

13.

Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1.

Lin X, Parisiadou L, Sgobio C, Liu G, Yu J, Sun L, Shim H, Gu XL, Luo J, Long CX, Ding J, Mateo Y, Sullivan PH, Wu LG, Goldstein DS, Lovinger D, Cai H.

J Neurosci. 2012 Jul 4;32(27):9248-64. doi: 10.1523/JNEUROSCI.1731-12.2012.

14.

Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.

Ferris MJ, Calipari ES, Mateo Y, Melchior JR, Roberts DC, Jones SR.

Neuropsychopharmacology. 2012 Jun;37(7):1708-16. doi: 10.1038/npp.2012.17. Epub 2012 Mar 7.

15.

Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors.

Bello EP, Mateo Y, Gelman DM, Noaín D, Shin JH, Low MJ, Alvarez VA, Lovinger DM, Rubinstein M.

Nat Neurosci. 2011 Jul 10;14(8):1033-8. doi: 10.1038/nn.2862.

16.

Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice.

Kramer PF, Christensen CH, Hazelwood LA, Dobi A, Bock R, Sibley DR, Mateo Y, Alvarez VA.

J Neurosci. 2011 Jan 5;31(1):126-32. doi: 10.1523/JNEUROSCI.4287-10.2011.

17.

Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration.

Ferris MJ, Mateo Y, Roberts DC, Jones SR.

Biol Psychiatry. 2011 Feb 1;69(3):201-7. doi: 10.1016/j.biopsych.2010.06.026.

18.
19.

Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis.

Fernández-Pastor B, Mateo Y, Gómez-Urquijo S, Javier Meana J.

Psychopharmacology (Berl). 2005 Jul;180(3):570-9. Epub 2005 Feb 17.

PMID:
15717207
20.

Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation.

Mateo Y, Lack CM, Morgan D, Roberts DC, Jones SR.

Neuropsychopharmacology. 2005 Aug;30(8):1455-63.

21.
22.

Fast onset of dopamine uptake inhibition by intravenous cocaine.

Mateo Y, Budygin EA, Morgan D, Roberts DC, Jones SR.

Eur J Neurosci. 2004 Nov;20(10):2838-42.

PMID:
15548229
23.

Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine.

Budygin EA, Brodie MS, Sotnikova TD, Mateo Y, John CE, Cyr M, Gainetdinov RR, Jones SR.

Proc Natl Acad Sci U S A. 2004 May 18;101(20):7781-6. Epub 2004 May 10.

24.

Role of serotonin in cocaine effects in mice with reduced dopamine transporter function.

Mateo Y, Budygin EA, John CE, Jones SR.

Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):372-7. Epub 2003 Dec 22.

25.

Chronic ethanol exposure alters presynaptic dopamine function in the striatum of monkeys: a preliminary study.

Budygin EA, John CE, Mateo Y, Daunais JB, Friedman DP, Grant KA, Jones SR.

Synapse. 2003 Dec 1;50(3):266-8. No abstract available.

PMID:
14515345
26.

Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.

Budygin EA, John CE, Mateo Y, Jones SR.

J Neurosci. 2002 May 15;22(10):RC222. Epub 2002 May 10.

28.

Effects of central noradrenaline depletion by the selective neurotoxin DSP-4 on the behaviour of the isolated rat in the elevated plus maze and water maze.

Lapiz MD, Mateo Y, Durkin S, Parker T, Marsden CA.

Psychopharmacology (Berl). 2001 May;155(3):251-9.

PMID:
11432687
29.

Effects of noradrenaline depletion in the brain on response on novelty in isolation-reared rats.

Lapiz MD, Mateo Y, Parker T, Marsden C.

Psychopharmacology (Berl). 2000 Oct;152(3):312-20.

PMID:
11105942
30.

Supplemental Content

Support Center